Using the Benford’s Law as a First Step to Assess the Quality of the Cancer Registry Data by Emanuele Crocetti & Giorgia Randi
ORIGINAL RESEARCH
published: 13 October 2016
doi: 10.3389/fpubh.2016.00225
Edited by:
Ming Wu,
Jiangsu Provincial Center for Disease
Control and Prevention, China
Reviewed by:
Stefano Guzzinati,
Istituto Oncologico Veneto, Italy
Xiaojin Yu,
Southeast University, China
*Correspondence:
Emanuele Crocetti
emanuele.crocetti@ec.europa.eu
Specialty section:
This article was submitted to
Epidemiology, a section of the
journal Frontiers in Public Health
Received: 11 August 2016
Accepted: 28 September 2016
Published: 13 October 2016
Citation:
Crocetti E and Randi G (2016) Using
the Benford’s Law as a First Step to
Assess the Quality of the Cancer
Registry Data.
Front. Public Health 4:225.
doi: 10.3389/fpubh.2016.00225
Using the Benford’s Law as a First
Step to Assess the Quality of the
Cancer Registry Data
Emanuele Crocetti* and Giorgia Randi
Health in Society Unit, Directorate F Health, Consumers and Reference Materials, Joint Research Centre (JRC), European
Commission, Ispra, Italy
Background: Benford’s law states that the distribution of the first digit different from 0
[first significant digit (FSD)] in many collections of numbers is not uniform. The aim of this
study is to evaluate whether population-based cancer incidence rates follow Benford’s
law, and if this can be used in their data quality check process.
Methods: We sampled 43 population-based cancer registry populations (CRPs) from
the Cancer Incidence in 5 Continents-volume X (CI5-X). The distribution of cancer
incidence rate FSDwas evaluated overall, by sex, and by CRP. Several statistics, including
Pearson’s coefficient of correlation and distance measures, were applied to check the
adherence to the Benford’s law.
Results: In the whole dataset (146,590 incidence rates) and for each sex (70,722
male and 75,868 female incidence rates), the FSD distributions were Benford-like.
The coefficient of correlation between observed and expected FSD distributions was
extremely high (0.999), and the distance measures low. Considering single CRP (from
933 to 7,222 incidence rates), the results were in agreement with the Benford’s law, and
only a few CRPs showed possible discrepancies from it.
Conclusion: This study demonstrated for the first time that cancer incidence rates follow
Benford’s law. This characteristic can be used as a new, simple, and objective tool in data
quality evaluation. The analyzed data had been already checked for publication in CI5-X.
Therefore, their quality was expected to be good. In fact, only for a few CRPs several
statistics were consistent with possible violations.
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INTRODUCTION
The Benford’s law (1), originally identified by Newcomb (2), states that in many numerical series
the distribution of the first significant digits (FSDs) (the first non-zero digit on the left side of a
number) is not uniform. In fact, for numbers which adhere to this law, the probability of 1 to be
the FSD is 30.1%, and this probability steadily decreases for the following digits up to 9, which is
the least common leading digit (4.6% of the cases). A distribution abides by the Benford’s law if the
frequency [F(x)] of the FSD, x2 {1, : : :, 9}, follows the logarithmic relation, F (x) = log10
 
1+ 1x

(1). The law of “anomalous numbers” applies also to the frequency of digits in other positions (1).
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Not all the numbers abide by the Benford’s law, but for those
which do, violations raise concerns. For example, in accounting
and auditing, also at a Governmental level, the Benford’s law has
been widely used to detect possible frauds (3–5).
Population-based cancer registries produce a great amount of
numbers: the cancer incidence rates. The evaluation of their qual-
ity is rather complex, involving different aspects, and it is mainly
based on the knowledge of the clinical, diagnostic, and therapeutic
pathways of patients and on the process of data collection and
registration (6, 7).
The most renowned publication on cancer incidence is Cancer
Incidence in 5 Continents (CI5) (8). The cancer registries sub-
mitting their data to CI5 have to pass a formal quality evalua-
tion before being accepted. The data quality assessment implies
checking the internal coherence, consistency, completeness, and
comparability with the final decision taken by a group of experts
in the field.
The aim of this study is to evaluate if cancer incidence rates
adhere to the Benford’s law to use this mathematical characteristic
as a further and objective tool for their quality evaluation.
MATERIALS AND METHODS
In the website of the CI5 volume X (CI5-X) (9), the data of the
290 population-based cancer registries included in the publication
are available, detailed by all the 424 cancer registry populations
(CRPs), as each cancer registry can provide information not only
for the whole population but also for different racial and/or ethnic
subgroups within the same population.
The CI5-X data include aggregated information for 244 com-
binations of cancer site and morphological group, specified for 19
age groups (5-year age groups from0–4 to 85+, plus unknown age)
and for the two sexes.
We drew a pseudorandom sample of 10% of the available CRPs,
stratified by continent (considering South and North America
separately), setting a random number seed to make the sampling
reproducible.
Overall, 43 CRPs (from 40 cancer registries) were sampled
and included in the analysis: 1 from Africa (Malawi, Blan-
tyre), 3 from Central and South America (Argentina, Tierra del
Fuego; Brazil, San Paolo and Ecuador, Quito), 18 from USA
(Virginia, Asian and Pacific Islanders; Nebraska, Black; Ohio;
Vermont; Montana; Michigan; Georgia; Indiana, White; Mis-
souri, White; NPCR-National program of cancer registries –
including 42 States; Colorado, Asian and Pacific Islanders;
Arkansas, Black; Alabama, White; Arkansas, White; California,
Asian and Pacific Islanders; Connecticut, Black; Virginia, Black;
and California), 7 from Asia (India, Karunagappally; Singa-
pore, Malay; Turkey, Edirne; Israel, Jews; Japan, Hiroshima Pre-
fecture; Japan, Fukui Prefecture; and Israel), 11 from Europe
(France, Isère; Germany, North Rhine – Westphalia; France,
Hérault; UK, England; Estonia; Switzerland, St Gall-Appenzell;
Bulgaria; Malta; Ukraine; Spain, Navarra; and Italy, Sondrio),
and finally 2 from Oceania (New Zealand; Other and USA, and
Hawaii).
The cancer data corresponding to the age group 19 (age
unknown) were excluded from the analysis.
After the exclusion of those combinations of cancer morphol-
ogy and site with no cases, 146,590 combinations were included
in the analysis.
Crude incidence rates were computed for each sex, age group,
and topography and morphology combination dividing the num-
ber of cases by the corresponding population, and expressed per
100,000 inhabitants. The FSD distribution for crude incidence
rates was then calculated for all the CRPs together, by sex, and
by CRP. Moreover, a sensitivity analysis has been performed ran-
domly excluding half of the most important cancer sites (prostate,
lung, breast, and colon–rectum).
For checking the adherence of observed FSD distributions to
the Benford’s one, we used different methods.
Since the Benford’s distribution has mean greater than median
and is positively skewed (10), these figures have been evaluated for
cancer incidence rates.
Theoretical and observed distributions were plotted for a
graphical comparison.
According to the literature, we did not use those tests (e.g., χ2
and the Kuiper’s statistic) that are extremely sensitive in rejecting
the null hypothesis (being a distribution Benford-like) for large
samples (4, 11–13). To test the goodness of fit, we used the
following tests:
– r: the Pearson correlation. This is commonly used to mea-
sure how closely a distribution follows the Benford’s law
(11, 12). The most the coefficient “r” is close to+1 the highest
the correlation between Benford’s law and the observed FSD
distribution is.
– χ2/n: the χ2 divided by the sample size (4, 14).
– m: the maximum distance in absolute terms between expected
and observed frequencies for each of the nine digits (1–9). The
statistics may vary between 0 (no differences between the two
distributions) to +1 (maximum difference) and the corre-
sponding formula is m=maxi= 1, 2, : : :, 9{|bi ei|} (12), where
bi is the frequency expected by Benford and ei is the observed
frequency for each digit i.
– d*: the normalized Euclidean distance between the two dis-
tributions divided by the maximum possible distance, which
would occur when the FSD was 9 for all the numbers. The
corresponding formula is:
d =
vuut 9X
i=1
(bi   ei)2
.vuut 8X
i=1
(bi)2 + (1  e9)2
where bi is the frequency expected by Benford and ei is the
observed frequency for each digit i. The statistic may vary
between 0 (no differences) to 1 (maximum difference) (12).
– Z statistic: the average of the Z values for each com-
parison between the nine observed and theoretical digits
distributions (5):
Z = 19
9X
i=1
p
n
"
j bi   eij   1= (2n)p
bi (1  bi)
#
where i= 1, : : :, 9 is a fixed digit, bi is the frequency expected
by Benford, and ei is the observed frequency for each digit i. The
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cut-off value for statistical significance, with alpha= 0.05 and one
side tail, is 1.64.
For providing an inter-CRP comparison, themean, themedian,
and the 10th or the 90th (the one including the most extreme
values) percentile of each statistic were computed.
A summation index has been computed for rating the CRPs
according to the statistics’ results. EachCRP received one point for
each statistic in the 10th or 90th percentile (whichever represents
the worst values). The summation index could vary from 0 (no
statistic beyond the threshold) up to 5 (all statistics beyond the
threshold). The probability for each statistic to be in the most
extreme decile was 0.1 (approximately 4/43) assuming indepen-
dence between statistics, considering that the summation index
follows a binomial distribution (pr= 0.1, n= 5) the randomprob-
ability for a CRP to have the summation index equal to 0 is 0.59, to
1 is 0.33, to 2 is 0.07, to 3 is 0.008, to 4 is 0.0005, and to 5 is 0.00001.
The analysis has been performed with Stata v. 12, using specific
commands for extracting the sample (“sample” and “seed”) and
for computing observed and Benford FSD distributions (“digdis”).
RESULTS
When considering all the cancer incidence rates together (146,590
observations), the distribution of the FSDs appeared to be posi-
tively skewed (0.84), with themean (3.38) greater than themedian
(3.0). These values were close to those of the theoretical Benford’s
distribution (skewness 0.8, mean 3.44, and median 3.0), as were
the ratios between 1st vs. 9th (observed 6.6 vs. Benford 6.6), and
between 1st vs. 2nd (1.8 vs. 1.7) FSD.
These results let suppose that the FSD distribution of cancer
incidence rates might adhere to the Benford’s pattern. In fact,
when the observed FSD distribution was graphically compared
to the theoretical one, as shown in Figure 1, they were almost
overlapping.
The Pearson’s correlation coefficient, r, showed an almost per-
fect direct correlation between the observed FSD distribution
and the expected one (0.999); moreover, all the measures of the
distance between the distributions were very low (m= 0.014 and
FIGURE 1 | Benford (line) and observed (columns) distributions of first
digits for all crude cancer incidence rates.
d*= 0.015), and the average Z was below the significance level.
Finally, the χ2 test, weighted on the number of observations
(χ2/n), was also very low (0.002).
The analysis has been repeated by sex and confirmed the same
results (data not shown). Also, after the exclusion of half of the
rates for the major cancer sites were excluded the overall results
confirmed the adherence of the FSD distribution to Benford’s law
(r= 0.999,m= 0.014, d*= 0.016, χ2/n= 0.002).
When single CRPs were evaluated, each FSD distribution was
positively skewed, and themeanwas greater than themedian (data
not shown).
In Figure 2, the FSD distribution of all cancer incidence rates
and the Benford distribution were compared for each of the 43
analyzedCRPs. The shapes of all distributions generally resembled
the Benford’s one, with a decreasing percentage of FSD from 1 to
the 9. However, a few possible differences were shown.
The Pearson correlation coefficients were very high for the
majority of the CRPs (median= 0.97); however, some values were
relatively low (0.85 representing the 10th percentile). Also, the
other measures of distance were generally low (median:m= 0.05,
d*= 0.07), but still the corresponding 90th percentiles reached
rather higher values (0.10 and 0.12, for m and d*, respectively).
For the ratio between the χ2 and the number of rates, the 90th
percentile was almost 3-time the median (90th percentile= 0.14
and 50th percentile= 0.05), and, finally, for the average Z, the
value of the 90th percentile corresponded to the value of statistical
significance (1.64).
Although the majority of the CRPs reported statistics showing
an agreement with the Benford’s law, for a few of them, the values
seemed to indicate possible discrepancies.
For 35 CRPs, the summation index was 0, for 4 CRPs
was 1, and for 2 CRPs was 2. Only one CRP (Argentina,
Tierra del Fuego) reported a summation index of 3 (r= 0.839;
d*= 0.125; χ/n= 0.146) and another one (USA, Virginia, Black)
had all the five statistics in the worst classes (r= 0.82; m= 0.13;
d*= 0.147; χ/n= 0.182; Z= 1.88). The probability for the two
latter results to happen by chance is very low. Therefore, for
such CRPs, a possible violation of the Benford’s law should be
considered.
DISCUSSION
In the present study, a considerable and heterogeneous sample of
CRPs, included in CI5-X, was analyzed to evaluate, for the first
time to our knowledge, if the FSD distribution of cancer incidence
rates abided by the Benford’s law.
The results showed a substantial adherence of FSD distribution
of cancer incidence rates to the Benford’s law.
This was not surprising. In fact, FSD distribution of cancer
incidence rates had a priori some characteristics for being Benford
prone. Indeed, they are the second generation distribution, being
the result of the division of the number of cases diagnosed in a
time span by the corresponding resident population, they com-
prise a large range of numbers covering several orders of magni-
tude (from units to thousands per 100,000 people, according to
different ages and cancer types), and they are not influenced by
human thought (15, 16).
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FIGURE 2 | Theoretical (line) and observed distributions (columns) of first digits for all the analyzed incidence rates, by registries and populations
(reg). 1: Malawi, Blantyre; 2: Argentina, Tierra del Fuego; 3: Brazil, San Paolo; 4: Ecuador, Quito; 5: USA, Virginia, Asian and Pacific Islanders; 6: USA, Nebraska,
Black; 7: USA, Ohio; 8: USA, Vermont; 9: USA, Montana; 10: USA, Michigan; 11: USA, Georgia; 12: USA, Indiana, White; 13: USA, Missouri, White; 14: USA,
NPCR-National program of cancer registries (including 42 States); 15: USA, Colorado, Asian and Pacific Islanders; 16: USA, Arkansas, Black; 17: USA, Alabama,
White; 18: USA, Arkansas, White; 19: USA, California, Asian and Pacific Islanders; 20: USA, Connecticut, Black; 21: USA, Virginia, Black; 22: USA, California; 23:
India, Karunagappally; 24: Singapore, Malay; 25: Turkey, Edirne; 26: Israel, Jews; 27: Japan, Hiroshima Prefecture; 28: Japan, Fukui Prefecture; 29: Israel; 30:
France, Isère; 31: Germany, North Rhine – Westphalia; 32: France, Hérault; 33: UK, England; 34: Estonia; 35: Switzerland, St Gall-Appenzell; 36: Bulgaria; 37: Malta;
38: Ukraine; 39: Spain, Navarra; 40: Italy, Sondrio; 41: Germany, Brandemburg; 42: New Zealand: Other; 43: USA, Hawaii.
We verified that cancer incidence rates respect the quantitative
measures suggested by Wallace (10) to assess whether a distri-
bution may be expected to obey the Benford’s law. In fact, the
mean of their observed FSD is greater than the median, and their
distribution has a positive skewness.
In the present study using graphical visualization, correlation
coefficient, and some distance statistics, we observed that FSD
distribution of cancer incidence rates abide by the Benford’s law
when analyzed overall, by sexes, excluding half of the rates for
the major cancer sites (female breast, colon–rectum, and lung and
prostate cancers) and generally by CRP.
We have analyzed data which had been already examined for
their quality and proved as good for publication in CI5-X (8).
Therefore, no major problems in data quality were expected.
In fact, our results showed that for almost all the CRPs the
FSD distribution substantially adhere to the Benford’s law. When
the 43 CRPs were analyzed individually, the plot of their FSD
distribution seemed to be in agreement with the Benford’s law.
It must be mentioned that, due to sampling, two CRPs were sub-
groups of the same registry (USA,Arkansas Black andWhite; USA
Virginia, Asian and Pacific Islanders and Black) and two others
included a subgroup and thewhole population of the same registry
(Israel and Israel, Jews and USA California and USA California,
Asian and Pacific Islanders). No large difference within those
cancer registries has been shown. Therefore, quality of cancer
registry data and related activity (in terms of data availability, data
collection, etc.) seemed not related to racial/ethnic subgroups at
least in the analyzed registries.
The cancer registry data quality evaluation is not a perfect
process, and some residual heterogeneity could exist also in CRPs
included in CI5-X. In fact, in the introduction of CI5-X, it is
stated that in the registry specific pages for someCRPs “an asterisk
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preceding the registry title indicates that special considerations
(whichmay include underregistration)must be taken into account
in interpreting the published rates or indicators of quality: : :”
(8). Overall, asterisks were reported for 114/424 CRPs in CI5-
X (26.9%), and in 11/43 (25.6%) in our sample. One of the two
CRPs which had three or more statistics with the worst values for
Benford’s compliance had the asterisks (50%), in comparison with
the others in the sample (10/31, 24.3%).
We evidenced that, although the majority of CRPs seemed to
adhere to the Benford’s law, at least two of them showed possible
violation. Random fluctuations could have driven the observed
results (14), even if with a very low probability, but the coherence
across the different applied statistics made, for these CRPs, the
inconsistency with the Benford’s distribution more probable.
According to our experience, based on the analyzed dataset
that has been already checked for data quality and accepted for
publication (CI5-X), cancer registries showing the poorest results
had r value below 0.9 andm, χ2/n, and d* values higher than 0.10;
presumably in a wild situation, greater values are expected.
The adherence to Benford’s law has been widely used not only
to detect fraudulent data in business and administration (3) but
also to test data irregularities in scientific research (17). Frauds in
cancer incidence data are not expected. However, non-adherence
to the law may be a clue for further evaluation. The distance from
the expected distribution may be the consequence of selections or
incompleteness of the data collection, of rounding of small rates
(18), of errors in data recoding or in data transfer.
The meaning of Benford’s violation is a red flag showing an
unusual behavior requesting further data examination (14). Once
the suspect for a violation is raised, a CRP, which owns more
data than those we analyzed, should try to find out clues for the
possible problem. Our suggestion is to look for the Benford patter
for incident cases based on different (combinations of) sources of
information (pathology reports, hospitalization, death certificate,
etc.) to detect any source-specific pattern. Moreover, it should
be evaluated the stability over time of the data flow, for each
information source and cancer site.
CONCLUSION
Checking for adherence to the Benford’s law is not suggested
in place of the traditional cancer registry data quality process,
but it could be used as a simple and objective tool in the first
steps to identify those cancer registries to be evaluated with great
attention.
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